Evommune, Inc. EVMN
6.04 USD +0.10 (+1.68%)
At closeNov 4, 2026, 7:34 PM EST
6.54 +0.50 +8.28%
After hours · Nov 4, 7:34 PM ET
5.82 Day range 6.30
5.10 52-week range 31.57
- YTD
- -64.72%
- 1 year
- -70.14%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
| 13.00M | 7.00M | 5.00M | |
| 13.00M | 7.00M | 5.00M | |
| -81.07M | -70.01M | -37.85M | |
| -68.87M | -66.81M | -34.05M | |
| -11.22 | -45.29 | -3.19 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
| 45.48M | 16.46M | 29.23M | |
| 224.95M | 76.06M | 82.25M | |
| 19.38M | 28.52M | 10.59M | |
| 1.71M | 1.02M | 1.26M | |
| 205.57M | -144.24M | -77.71M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
| -76.44M | -58.20M | -29.97M | |
| -115.31M | -3.99M | -48.43M | |
| 220.76M | 49.42M | 63.75M | |
| -235.00K | -88.00K | -118.00K | |
| 29.02M | -12.77M | -14.65M |
